Results 171 to 180 of about 34,737 (245)

Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget. [PDF]

Sci Rep
Atta AM, Nafie MS, Ali HA, Saleh HK, Roshdy MA, Mahmoud MM, Eid EA, Ahmed MA, Gerges MS, Ghoneim AM, Refaie AH, Attia EE, Algandaby MM, Darwish KM.   +13 more
europepmc   +1 more source

The molecular basis of intrinsic resistance to azoles in <i>Rhizopus arrhizus</i>. [PDF]

Antimicrob Agents Chemother
Lackner M, Toepfer S, Keniya MV, Lax C, Nicolas FE, Garre V, Müller C, Rosam K, Zenz L-M, Cesarini L, Binder U, Tyndall JDA, Monk BC.   +12 more
europepmc   +1 more source

Diselenide-enabled photocatalytic hydroazolation of <i>gem</i>-difluoroalkenes. [PDF]

Chem Sci
Abd El-Gaber MK, Herrick RM, Sudhakar P, Rana A, Roach BA, Dick JE, Altman RA.   +6 more
europepmc   +1 more source

Natural-Compound Adjuvants Dismantle Candida Biofilms: Mechanisms, Design Rules, and Biofilm-Aware Pharmacology. [PDF]

Curr Microbiol
Tuan DA, Masak J.
europepmc   +1 more source

Synthesis of 1-(pyrrolidin-2-ylmethyl)-1H-azoles and their piperidine-derived homologues

Open Chemistry, 2014
Zhersh Sergey, Karpenko Oleksandr, Ripenko Vasyl, Tolmachev Andrey, Grygorenko Oleksandr   +4 more
doaj   +1 more source

From crops to clinic: the impact of dual azole use on antifungal resistance in <i>Candida</i> and <i>Candida</i> associated yeasts. [PDF]

Front Microbiol
Allison JC, Hyland EM.
europepmc   +1 more source

A Comprehensive Overview of <i>Candida albicans</i> as the Leading Pathogen in Vulvovaginal Candidiasis. [PDF]

J Fungi (Basel)
Srb N, Talapko J, Meštrović T, Fureš R, Stupnišek M, Srb AM, Škrlec I.   +6 more
europepmc   +1 more source

Antifungal Resistance and Synergistic Therapy in Candida Spp. Isolated From Bottlenose Dolphins Under Human Care: Implications for One Health Management. [PDF]

Vet Med Sci
Biancani B, Mauri F, Nezio FD, Binanti D, Furlati S, Roman S, Matteucci G.   +6 more
europepmc   +1 more source

Screening for toxicity of azole fungicides in <i>Caenorhabditis elegans</i> identifies triflumizole as a potent reproductive and developmental toxicant. [PDF]

MicroPubl Biol
Hughes S, Koopmans C, van Duursen M.
europepmc   +1 more source

Comparative Analysis of Isavuconazole DDIs With Other Azole Antifungal Drugs and PBPK Model-Informed Dosing Recommendations for Anticancer Drugs. [PDF]

CPT Pharmacometrics Syst Pharmacol
Goosen TC, Wu X, Lin J, Cheruvu N, Raber SR, de Figueiredo MLN, Varma MVS.   +6 more
europepmc   +1 more source